We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 0.66% | 61.20 | 61.60 | 63.80 | 64.60 | 61.60 | 62.60 | 107,324 | 16:35:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 11.58M | -28.29M | - | N/A | 42.94M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/3/2020 15:40 | If you really want a corona virus play, look into (WEY) education online education, benefiting from the global closures of schools/universities dyor as usual Group turnover for the year to 31 August 2020 is expected to be significantly ahead of market forecasts and to be in excess of GBP7.5m, which would represent an increase of over 25% on the year ended 31 August 2019. | ny boy | |
04/3/2020 15:39 | Albert will be chewed and spat out. | moneymachine2 | |
04/3/2020 15:37 | Albert is only a talker. | moneymachine2 | |
04/3/2020 15:34 | Looks like 85p new support | iamgreat1 | |
04/3/2020 15:29 | Any good shares in undertakers | dazzerman4 | |
04/3/2020 15:23 | Go on Albert.. | demking1 | |
04/3/2020 15:23 | Albert=chimers | andymunchkin | |
04/3/2020 15:22 | As If anyone is going to listen to you.. you are biggest cvnt on ADVFN..Get back to bookies where you belong scrote.. | bullrun1 | |
04/3/2020 15:19 | Yes we need more kits, and millions to be conservative.... But unlikely to be NCYT's kitThat's why the price is dropping, fundamentals and not shorters ... As I have said repeatedly, the company has missed a great opportunity to be at the forefront of diagnosis, but now is one of the pack | yet another final | |
04/3/2020 15:17 | HungryFer blood Or thirdtyFer pish. Udecide regardless | andymunchkin | |
04/3/2020 15:15 | @ 15pm itHits 95 ,5is the magicNo. 95-75-55-45-35-25-15 | andymunchkin | |
04/3/2020 15:13 | funding investors above. | hazl | |
04/3/2020 15:12 | LyingGames orCryingGames UDecide | andymunchkin | |
04/3/2020 15:11 | CityBoys upset,theyCouldnt haveTheir way so now theyR hungry fer blood cueIn Sxx | andymunchkin | |
04/3/2020 15:10 | NOVACYT Has various areas of expertise. When it was first admitted to the stock exchange.... 'admission to the AIM market, today, 1 November 2017, under the ticker "NCYT" (ISIN: FR0010397232). The Novacyt Group is a rapidly growing, international diagnostics group generating revenues from cancer, haematology, serology and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular diagnostic platform, genesig®, Novacyt is able to provide an extensive range of diagnostic products across a broad international distributor network and to major corporate partners. The Company has a strong track record of growth, delivering 56% CAGR between 2014 and 2016. Summary of the Fundraising €9.7 million (before expenses) raised through the Fundraising The Fundraising consisted of €4.7 million of Placing Shares and €5.0 million of Subscription Shares, both at an issue price of 59.38 pence per Share (€0.66) (the “Issue Price”) The number of Ordinary Shares in issue on AIM Admission will be 37,664,341, giving the Company an anticipated market capitalisation of approximately £22.4 million at the Issue Price Reasons for Admission and Use of Proceeds Following the Company's acquisition of Primerdesign in May 2016, the Group has become a more UK-centric company, with clear growth plans. The Directors believe that the admission to AIM is an important step in the Company's development, providing access to a deeper potential pool of capital whilst raising its international and capital markets ......' | hazl | |
04/3/2020 15:06 | 'Data include both confirmed and presumptive positive cases of COVID-19 reported to CDC or tested at CDC since January 21, 2020. This table does not include information on testing results of persons repatriated to the United States from Wuhan, China and Japan. States are now testing and publicly reporting their cases. In the event of a discrepancy, state case counts are the most up to date. † CDC is no longer reporting the number of persons under investigation (PUIs) that have been tested, as well as PUIs that have tested negative. Now that states are testing and reporting their own results, CDC’s numbers are not representative all of testing being done nationwide. ' interesting | hazl | |
04/3/2020 15:05 | TimberR type | andymunchkin | |
04/3/2020 15:04 | Still collecting wood....Watch the space. | albert arthur | |
04/3/2020 15:01 | Hazl manUp | andymunchkin |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions